Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

AVAILABLENot Applicable

NCT04132882

A Compassionate Use Program to Provide Access to Sodium Thiosulfate

This is a CUP which is designed to provide treatment access of STS to pediatric patients for the protection from Cisplatin-Induced Hearing Loss in children who…

Turkey (Türkiye)

Treatment: Sodium Thiosulfate (STS)